Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 814.85M P/E - EPS this Y 4.00% Ern Qtrly Grth -
Income -95.99M Forward P/E -6.69 EPS next Y -7.90% 50D Avg Chg 33.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 56.00%
Dividend N/A Price/Book 5.17 EPS next 5Y - 52W High Chg -21.00%
Recommedations 1.80 Quick Ratio 7.21 Shares Outstanding 54.45M 52W Low Chg 254.00%
Insider Own 7.95% ROA -41.54% Shares Float 39.88M Beta 1.05
Inst Own 87.32% ROE -107.50% Shares Shorted/Prior 6.31M/6.24M Price 18.41
Gross Margin - Profit Margin - Avg. Volume 701,819 Target Price 48.88
Oper. Margin - Earnings Date May 9 Volume 377,642 Change -3.51%
About Vera Therapeutics, Inc.

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is in Phase II clinical trial. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

Vera Therapeutics, Inc. News
04/23/24 Health Care Roundup: Market Talk
04/13/24 Could This Stock Be the Next Biotech Buyout?
04/12/24 Insider Sells at Vera Therapeutics Inc: SVP, Finance, Chief Accounting Officer Joseph Young ...
04/11/24 Vertex Pharmaceuticals to buy Alpine Immune Sciences in $4.9B deal
04/05/24 ARS Pharmaceuticals, Nuvalent, and More Stocks See Action From Activist Investors
04/02/24 Vera Therapeutics Announces Two Oral Presentations at the 61st European Renal Association Congress
03/20/24 Vera Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
02/28/24 Vera Therapeutics to Participate at the 44th Annual TD Cowen Health Care Conference
02/11/24 Estimating The Fair Value Of Vera Therapeutics, Inc. (NASDAQ:VERA)
02/02/24 Vera Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
02/01/24 Vera Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares in Public Offering of Class A Common Stock
01/29/24 Vera Therapeutics Announces Pricing of Upsized Public Offering of Class A Common Stock
01/29/24 Vera Therapeutics Announces Proposed Public Offering of Class A Common Stock
01/25/24 Vera Therapeutics Presents Positive 72-Week Data Showing eGFR Stabilization in the Phase 2b ORIGIN Clinical Trial OLE in IgA Nephropathy
01/12/24 Why Vera Therapeutics Stock Soared by 22% This Week
01/08/24 Vera Therapeutics Announces Appointment of Industry Veterans Robert Brenner, M.D. as Chief Medical Officer and William D. Turner as Chief Development Officer
01/08/24 Vera Therapeutics to Host In-Person R&D Day in New York to Present Week 72 Data from Phase 2b ORIGIN Clinical Trial of Atacicept in IgAN on January 25, 2024
01/01/24 Pleasing Signs As A Number Of Insiders Buy Vera Therapeutics Stock
12/27/23 Vera Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
12/15/23 This Promising Small-Cap Biotech Stock Could Rise 70%, According to Wall Street
VERA Chatroom

User Image Scientwist Posted - 11 hours ago

$VERA Thank You! Sold! Taxes paid! Blowing it all in Tampa! Good Luck everyone!

User Image WallStreetBuyDip Posted - 1 day ago

Many traders buy the random level and lose while I get a reversal trade 95%+ of the time. Learn what low H% is. Will buy $VERA for a reversal trade when H% is low. What's your strategy in the market when making a trade? Algos are very complex. This shows why I ONLY buy when H% is low

User Image _jmed10 Posted - 4 days ago

$VERA sure about that one pal?

User Image Johndou9h Posted - 1 week ago

$VERU $CRMD $VERA $POAI Get ready for April 23! FDA Approval of a groundbreaking cancer drug developed by Los Angeles Times owner and inventor of Abraxane, which made in $9 billion richer and now produced by Bristol Myers. Get the shares before the run-up. I have over 400 followers, but I rarely make an announcement like this about a pre-FDA decision. High risk, high reward investment. Make your own financial decision after research

User Image vjtweet Posted - 1 week ago

$ARQ $VERA $HUBC $INDO $WAVE tomorrow’s long watchlist.

User Image GreenGoblin_ Posted - 1 week ago

$VERA put premiums way up here. Options flowing to calls. We shall see

User Image BoeingStingray Posted - 1 week ago

$VERA what an idiot.

User Image insiderbuyingselling Posted - 2 weeks ago

$VERA new insider selling: 5714 shares. http://insiderbuyingselling.com/?t=VERA

User Image BioRunner9 Posted - 2 weeks ago

$VERA retarded pricing moves here. Hope longs get torched

User Image BioRunner9 Posted - 2 weeks ago

$VERA move on

User Image victorcastro Posted - 2 weeks ago

$GL $CONN $MS $LCID $VERA

User Image BioRunner9 Posted - 2 weeks ago

$VERA So with Ph3 data in later half of 24, this run up seems massively overdone. How can one compare to the ALPN buyout. Great company but needs to retrace to low 40s.

User Image Capitulation_0 Posted - 2 weeks ago

$VERA some analyst thought this should've been taken out instead...

User Image ClassifiedTrades Posted - 2 weeks ago

$JANX rock skipping again $VERA $LPCN

User Image basscat12 Posted - 2 weeks ago

$ELYM $RENT $VERA $EU Pre-Market Gap Up, delayed, courtesy barchart, presented here for @Vegas1 to help follow the money!

User Image RallyRaider Posted - 2 weeks ago

$KDNY $VERA will get FDA approval in IGAN, i believe its taken out after that. After i got out around 31, ill buy some shares today. Alwas follow the money.

User Image RiskVsReward Posted - 2 weeks ago

$VERA Buckle up it's going to be an interesting ride! 🚨

User Image AlertsAndNews Posted - 2 weeks ago

Updated gappers in after hours $RENT $RLYB $ALPN $EFOI $VERA Enjoy your evening! 🌐

User Image Peterson28 Posted - 2 weeks ago

$ALPN $VERA The stupidest post I havent seen for a while. Nice joke.

User Image mdunbar Posted - 2 weeks ago

@Johndou9h $VERA $ALPN That is funny ... you think algos are that stupid!!! VERA went up as a sympathy play to ALPN buyout announcement because just like ALPN, VERA works on developing and commercializing treatments for immunological diseases and target BAFF and APRIL cytokines. Atacicept by VERA is a novel biologic investigational therapeutic: recombinant fusion protein containing the soluble TACI receptor that binds to the cytokines BAFF and APRIL Povetacicept (ALPN-303) by Alpine. Povetacicept is a dual B cell cytokine antagonist being developed for multiple autoimmune and/or inflammatory diseases. Based upon an engineered TACI (transmembrane activator and CAML interactor) domain, povetacicept in preclinical studies shows robust inhibition of B cell activating factor/B lymphocyte stimulator (BAFF, BLyS) and a proliferation inducing ligand (APRIL). Hope, you were not short VERA.

User Image Johndou9h Posted - 2 weeks ago

$VERA $ALPN Why did Vera's stock go up on no news? Because the algos and writers confused Vertex with Vera. It's Vertex that acquired Alpine, so only Alpine's share price should increase. You can see the spiking of the share prices at the same time when Vertex announced a takeover of Alpine. Algos got confused because of the similar names, and because they're both involved in kidney treatment and IgAN

User Image Johndou9h Posted - 2 weeks ago

$VERA

User Image tradingtwenty Posted - 2 weeks ago

Top 5 after-hours stocks that have trended in the past 24 hours: $RENT 58.38% 🔥 $ALPN 36.48% $VERA 13.07% $JANX 6.41% $RELL 5.88% Link: https://tradingtwenty.com/dashboard/trending/past

User Image MissHollandia Posted - 2 weeks ago

$SLNA 🤞😉☝☝☝ AH movers $RENT $ALPN $VERA $RLAY

User Image TheLionofwallstreet Posted - 2 weeks ago

$JAGX $VERA $IBIO This News Flew under the radar today but when word gets out it is going to be that Small cap bio squeeze we all know and love. Happy Squeezy Bulls! https://aimimmuno.com/aim-immunotech-announces-positive-top-line-protocol-planned-interim-report-data-from-the-study-of-ampligen-combined-with-pembrolizumab-for-the-treatment-of-recurrent-ovarian-cancer/

User Image Peterson28 Posted - 2 weeks ago

$VERA Competitor with a weaker drug got acquired for 4.9B. Sympathy rally. This would be acquired at 5B.

User Image GreenGoblin_ Posted - 2 weeks ago

$VERA 19 percent move off no news…. Skeptical.

User Image mohamed11114 Posted - 2 weeks ago

$VERA let's see $50 today

User Image prathikbose Posted - 2 weeks ago

$VERA short covers clearly

User Image stockpicker63 Posted - 2 weeks ago

$VERA wow more than 23% profit!

Analyst Ratings
Guggenheim Buy Apr 5, 24
Guggenheim Buy Mar 27, 24
Wedbush Neutral Mar 21, 24
Wedbush Neutral Jan 26, 24
Raymond James Strong Buy Jan 26, 24
Oppenheimer Outperform Jan 25, 24
Cantor Fitzgerald Overweight Jan 8, 24
HC Wainwright & Co. Buy Dec 27, 23
Raymond James Outperform Dec 18, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Katabi Maha Director Director Jan 30 Buy 31.00 161,290 4,999,990 3,628,446 02/01/24
COMMODORE CAPITAL LP 10% Owner 10% Owner Jan 10 Sell 18.00 1,050,000 18,900,000 4,400,000 01/12/24
Fordyce Marshall President and CEO President and CEO Dec 29 Option 2.61 13,516 35,277 256,877 01/03/24
Lin Celia Chief Medical Office.. Chief Medical Officer Aug 21 Sell 16.6547 1,490 24,816 11,010 08/23/23
Curley Joanne Chief Development Of.. Chief Development Officer Aug 21 Sell 16.6558 1,490 24,817 26,962 08/23/23
Fordyce Marshall President and CEO President and CEO Aug 21 Sell 16.6562 5,210 86,779 243,361 08/23/23
SEIDENBERG BETH C Director Director Feb 13 Buy 7.1972 10,072 72,490 1,664,702 02/15/23
SEIDENBERG BETH C Director Director Feb 09 Buy 7.25 400 2,900 1,654,630 02/13/23
Longitude Capital Partners IV,... 10% Owner 10% Owner Feb 06 Buy 7.00 1,714,285 11,999,995 1,714,285 02/08/23
ENRIGHT PATRICK G Director Director Feb 06 Buy 7.00 1,714,285 11,999,995 1,714,285 02/08/23
Sofinnova Venture Partners X,... 10% Owner 10% Owner Feb 06 Buy 7.00 285,714 1,999,998 3,467,156 02/08/23
Curley Joanne Chief Development Of.. Chief Development Officer Nov 09 Sell 16.54 494 8,171 27,315 11/10/22
Curley Joanne Chief Development Of.. Chief Development Officer Oct 18 Option 7.82 8,590 67,174 27,811 10/20/22
Curley Joanne Chief Development Of.. Chief Development Officer Oct 18 Sell 19.63 8,590 168,622 27,809 10/20/22
Fordyce Marshall President and CEO President and CEO Sep 07 Option 2.9 21,891 63,484 196,256 09/09/22
Fordyce Marshall President and CEO President and CEO Sep 07 Sell 20.28 21,891 443,949 181,150 09/09/22
Carlyle Group Inc. 10% Owner 10% Owner Aug 17 Option 11 9,925 109,175 2,970,156 08/19/22
Carlyle Group Inc. 10% Owner 10% Owner Aug 17 Sell 20.46 9,925 203,066 2,960,231 08/19/22
Fordyce Marshall President and CEO President and CEO Aug 12 Option 2.9 20,528 59,531 157,928 08/15/22
Fordyce Marshall President and CEO President and CEO Aug 12 Sell 20.16 20,528 413,844 137,400 08/15/22
Curley Joanne Chief Development Of.. Chief Development Officer Jul 19 Option 4.63 11,444 52,986 18,281 07/20/22
Curley Joanne Chief Development Of.. Chief Development Officer Jul 19 Sell 16.28 11,444 186,308 18,273 07/20/22
Curley Joanne Chief Development Of.. Chief Development Officer Jun 22 Option 6.37 1,239 7,892 25,233 06/23/22
Curley Joanne Chief Development Of.. Chief Development Officer Jun 22 Sell 15.02 1,545 23,206 23,688 06/23/22
Curley Joanne Chief Development Of.. Chief Development Officer Jun 17 Option 4.63 4,687 21,701 28,535 06/21/22
Curley Joanne Chief Development Of.. Chief Development Officer Jun 17 Sell 15.05 5,887 88,599 23,994 06/21/22
Longitude Capital Partners IV,... 10% Owner 10% Owner Feb 10 Buy 15.00 333,333 4,999,995 3,429,927 04/05/22
ENRIGHT PATRICK G Director Director Feb 10 Buy 15.00 333,333 4,999,995 3,429,927 04/05/22
Sofinnova Venture Partners X,... 10% Owner 10% Owner Feb 10 Buy 15 266,666 3,999,990 3,181,442 02/14/22